(In the Media)The reform about the development of clinical trial in Gene therapy in Japan: Prepared for reform of the Pharmaceutical Affairs Law for Regeneration Medical Products.(Jikkenigaku, the January 2016 edition)
date : 1/1/2016
Toshio Miyata, HGPI Executive Director, wrote an article entitled “The reform about the development of clinical trial in of Gene therapy: Prepared for reform of the Pharmaceutical Affairs Law for Regeneration Medical Products” Written by Toshio Miyata was featured in Jikkenigaku, January 2016, YODOSHA (in Japanese).
Top Research & Recommendations Posts
- [Recommendations] Proposal on a Global Procurement System for Coronavirus Disease 2019 (COVID-19) Vaccines (September 7, 2020)
- [Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)
- [Policy Recommendations] Furthering the Development of Precision Cancer Medicine —Proposals for Effective Policy Changes Based on Key Characteristics of Precision Medicine in Cancer Treatment— (September 20, 2022)
- [Announcement] HGPI Planetary Health Policy Team Signs Healthy Climate Prescription (August 31, 2022)
- [New Research Project] Initiative for the Advancement of Dementia Research and Social System Innovation through Global Public Private Partnerships (PPP)
